Candel Therapeutics Inc. (NASDAQ: CADL) Stock Information | RedChip

Candel Therapeutics Inc. (NASDAQ: CADL) Listen to this Section


$5.50
+0.1200 ( +2.23% ) 69.1K

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Market Data


Open


$5.50

Previous close


$5.38

Volume


69.1K

Market cap


$176.79M

Day range


$5.35 - $5.57

52 week range


$0.66 - $14.30

Insider Ownership Transactions

Total Amount Purchased: -153,821.00 | $ -846,015.50

Date Type Amount Purchased Purchaser
2024-06-27 Sale -14240.00 Benz Edward J. JR
2024-06-27 Sale -14240.00 PAPA JOSEPH C
2024-06-27 Sale -14240.00 Gaeta Renee
2024-06-27 Sale -14240.00 Loggia Nicoletta
2024-06-27 Sale -14240.00 Manning Paul B
2024-06-27 Sale -14240.00 Martell Christopher
2024-06-27 Sale -14240.00 Nabel Gary J.
2024-06-27 Sale -14240.00 Nguyen Diem
2023-11-30 Sale -20153.00 Amello Jason
2023-11-30 Sale -19748.00 Barone Francesca

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jul 15, 2024
4 Insider transactions 1 Jul 15, 2024
8-k 8K-related 11 Jun 28, 2024
4 Insider transactions 1 Jun 27, 2024
4 Insider transactions 1 Jun 27, 2024
4 Insider transactions 1 Jun 27, 2024
4 Insider transactions 1 Jun 27, 2024
4 Insider transactions 1 Jun 27, 2024
4 Insider transactions 1 Jun 27, 2024
4 Insider transactions 1 Jun 27, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.